The latest price target for Tenon Medical (NASDAQ:TNON) was reported by Maxim Group on November 15, 2024. The analyst firm set a price target for $8.00 expecting TNON to rise to within 12 months (a possible 213.73% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Tenon Medical (NASDAQ:TNON) was provided by Maxim Group, and Tenon Medical maintained their buy rating.

There is no last upgrade for Tenon Medical

There is no last downgrade for Tenon Medical.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenon Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenon Medical was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.

While ratings are subjective and will change, the latest Tenon Medical (TNON) rating was a maintained with a price target of $22.00 to $8.00. The current price Tenon Medical (TNON) is trading at is $2.55, which is out of the analyst’s predicted range.